Tag: angioplasty
DCB vs plain balloon AV access angioplasty: More investigation is needed,...
At the recent Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual meeting (14–18 September, Lisbon, Portugal), Kate Steiner (East and North Herts NHS...
New algorithm aims to provide clearer guidance on high AV access...
At the most recent American Society of Diagnostic and Interventional Nephrology (ASDIN) annual scientific meeting (23–25 February 2024, New Orleans, USA), Gerald Beathard (University...
Summa Therapeutics receive FDA approval for injectable angioplasty balloon catheter
Summa Therapeutics, a specialty angioplasty balloon medical device company, announced today that its innovative line of injectable angioplasty balloon catheters has been cleared for...
Seven key elements for effective compliance for vascular access providers are...
In a recent presentation at the VEITHsymposium 2023 (14–18 November, New York, USA), Terry Litchfield (president, Access Solutions) outlined what she believes to be...
Renal Interventions’ top 10 stories of May 2023
May saw comprehensive coverage of the 2023 Charing Cross Symposium (CX 2023; 25–27 April, London, UK), with deep dives into cost effectiveness and endovascular...
Angioplasty-assisted maturation effective “even for small cephalic veins”
It has been suggested by some, such as Khalid Bashar (University Hospital Limerick, Limerick, Ireland) et al in the International Journal of Surgery in...
Covered stent improves AVF angioplasty outcomes in new trial
The AVeNEW study, a 24-month multicentre, international, prospective and randomised clinical trial has published results investigating percutaneous transluminal angioplasty (PTA) compared to PTA with...
Live from ASDIN: DCB or not DCB? “Compelling” evidence demands more...
The second day of the 2023 meeting of the American Society of Diagnostic and Interventional Nephrology (ASDIN; 17–19 February, Orlando, USA) played host to...
Transit Scientific announces US FDA clearance for XO RX angioplasty platform
Transit Scientific has announced that the XO RX 2.2Fr and XO RX 3.8Fr platform has received US Food and Drug Administration (FDA) clearance to...
Continued clinical success reported with cutting-edge vessel prep device
Transit Scientific had shared via press release successful outcomes on multiple fistula and graft cases using its XO Score sheath platform, a first-of-its-kind metal-alloy...
Oversized balloon angioplasty technique safe and effective for AV fistula maturation
A retrospective analysis published in the Journal of Vascular Access (JVA) has shown that the oversized balloon angioplasty technique to assist arteriovenous (AV) fistula...
Concept Medical provides update on IMPRESSION trial to evaluate MagicTouch AVF
Concept Medical has provided an update on the progress of the IMPRESSION (sirolimus-coated balloon angioplasty versus plain balloon angioplasty in the treatment of dialysis access dysfunction)...
Treating venous stenosis: Experts agree re-evaluation of AV graft surveillance is...
In its current form, postprocedural surveillance of arteriovenous grafts (AVGs) used to treat venous stenosis is “little more than supervised neglect”, and should be...
XO Score scoring sheath platform gains CE mark to treat PAD...
Transit Scientific has announced CE mark clearance for its XO Score scoring sheath platform, allowing the technology to be used in the treatment of...